Table 3. Change in UC-Disease Activity Index Score at the End of Treatment.
Variable | Multimatrix-4.8 g/day | pH-3.6 g/day |
---|---|---|
Per protocol set | ||
No. of patients | 134 | 129 |
Mean±SD | −2.60±2.47 | −1.80±2.64 |
Differences between groupsa (95% CI) | −0.7 (−1.3 to −0.1) | - |
P-value | 0.017 | - |
Full analysis set | ||
No. of patients | 137 | 135 |
Mean±SD | −2.50±2.51 | −1.70±2.73 |
Differences between groupsa (95% CI) | −0.8 (−1.4 to −0.2) | - |
P-value | 0.009 | - |
Change in UC-DAI score=UC-DAI score at the end of treatment − UC-DAI score at baseline.
aDifferences in mean change in UC-DAI scores between groups, adjusted according to UC-DAI score at baseline (multimatrix-4.8 g/day–pH-3.6 g/day).
UC-DAI, UC-Disease Activity Index.